Measurement of voriconazole in serum and plasma
- 1 December 2007
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 40 (18), 1378-1385
- https://doi.org/10.1016/j.clinbiochem.2007.07.024
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Adverse Reactions to VoriconazoleClinical Infectious Diseases, 2004
- The Safety of VoriconazoleClinical Infectious Diseases, 2002
- Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: a Dose Escalation StudyThe Journal of Clinical Pharmacology, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised PatientsClinical Infectious Diseases, 2001
- Voriconazole: A New Triazole AntifungalAnnals of Pharmacotherapy, 2000
- Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in PlasmaAntimicrobial Agents and Chemotherapy, 2000
- In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvinMycoses, 1998
- Oral Azole Drugs as Systemic Antifungal TherapyNew England Journal of Medicine, 1994
- Mechanism of Action of Antifungal Drugs, with Special Reference to the Imidazole DerivativesClinical Infectious Diseases, 1980